Gain Therapeutics, Inc.

NasdaqGM:GANX Stock Report

Market Cap: US$46.7m

Gain Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:GANX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
09 Aug 24BuyUS$14,544Gene MackIndividual14,400US$1.01
09 Aug 24BuyUS$49,940Khalid IslamIndividual50,000US$1.00
01 Jul 24BuyUS$20,670Eric RichmanIndividual17,000US$1.23
28 Mar 24BuyUS$115,770Jeffrey RileyIndividual30,000US$3.86

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of GANX?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders1,300,7824.9%
Institutions1,679,4826.33%
General Public23,544,80488.8%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 75.4%.

Top Shareholders

Top 25 shareholders own 11.23% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
3.51%
Khalid Islam
930,784US$1.6m5.68%no data
2.13%
Greenlight Capital, Inc.
566,130US$996.4k0%0.04%
1.26%
Gotham Asset Management, LLC
334,592US$588.9k0%0.01%
1.15%
Eric Richman
304,458US$535.8k5.91%no data
1.03%
Geode Capital Management, LLC
271,972US$478.7k48%no data
0.55%
The Vanguard Group, Inc.
145,217US$255.6k0%no data
0.32%
BlackRock, Inc.
84,924US$149.5k0.36%no data
0.2%
Edward Jones Trust Company
53,500US$94.2k664%no data
0.2%
Renaissance Technologies LLC
53,264US$93.7k-55.1%no data
0.17%
Northern Trust Global Investments
44,944US$79.1k0%no data
0.14%
Prelude Capital Management, LLC
35,820US$63.0k0%no data
0.13%
State Street Global Advisors, Inc.
34,437US$60.6k0%no data
0.11%
Jeffrey Riley
30,000US$52.8k0%no data
0.08%
Matthias Alder
21,140US$37.2k0%no data
0.058%
Sandhill Capital Partners LLC
15,400US$27.1k0%no data
0.054%
Gene Mack
14,400US$25.3k0%no data
0.032%
UBS Asset Management AG
8,455US$14.9k-26%no data
0.018%
Tower Research Capital Europe Limited
4,842US$8.5k180%no data
0.018%
Simplex Trading, LLC, Asset Management Arm
4,801US$8.4k-47%no data
0.018%
Morgan Stanley, Investment Banking and Brokerage Investments
4,800US$8.4k45.5%no data
0.017%
Creekmur Asset Management, LLC
4,440US$7.8k0%no data
0.015%
Lord, Abbett & Co. LLC
4,071US$7.2k71.5%no data
0.013%
Merrill Lynch & Co. Inc., Banking Investments
3,375US$5.9k0%no data
0.01%
Wells Fargo & Company, Securities and Brokerage Investments
2,650US$4.7k0%no data
0.0053%
Group One Trading LP, Asset Management Arm
1,401US$2.5k-81.1%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/29 07:56
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Gain Therapeutics, Inc. is covered by 8 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Mayank MamtaniB. Riley Securities, Inc.
Thomas ShraderBTIG
Keay NakaeChardan Capital Markets, LLC